Psyence Biomedical Ltd. (PBM)

Psyence Biomedical Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Mar 31, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	0.73	0.73	1.33	2.19
Cash & Short-Term Investments	0.73	0.73	1.33	2.19
Cash Growth	-45.05%	-45.05%	-39.10%	-
Other Receivables	0.04	0.04	0.15	0.05
Receivables	0.04	0.04	0.15	0.05
Prepaid Expenses	0.32	0.32	0.08	0.01
Restricted Cash	0.03	0.03	0.03	0.04
Total Current Assets	1.13	1.13	1.59	2.29
Property, Plant & Equipment	0.01	0.01	-	-
Total Assets	1.13	1.13	1.59	2.29
Accounts Payable	0.56	0.56	1.63	0.05
Accrued Expenses	0.13	0.13	0.16	0.12
Short-Term Debt	10.45	10.45	-	-
Other Current Liabilities	0.97	0.97	-	-
Total Current Liabilities	12.1	12.1	1.79	0.16
Total Liabilities	12.1	12.1	1.79	0.16
Common Stock	46.13	46.13	5.93	2.12
Retained Earnings	-57.46	-57.46	-6.3	-
Comprehensive Income & Other	0.36	0.36	0.17	-
Shareholders' Equity	-10.97	-10.97	-0.2	2.12
Total Liabilities & Equity	1.13	1.13	1.59	2.29
Total Debt	10.45	10.45	-	-
Net Cash (Debt)	-9.71	-9.71	1.33	2.19
Net Cash Growth	-	-	-39.10%	-
Net Cash Per Share	-1.49	-1.49	0.27	-
Filing Date Shares Outstanding	13.39	13.39	5	-
Total Common Shares Outstanding	13.39	13.39	5	-
Working Capital	-10.98	-10.98	-0.2	2.12
Book Value Per Share	-0.82	-0.82	-0.04	-
Tangible Book Value	-10.97	-10.97	-0.2	2.12
Tangible Book Value Per Share	-0.82	-0.82	-0.04	-
Machinery	0.01	0.01	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.